Latest Headlines

Latest Headlines

Archimedes wins FDA approval for cancer pain spray

The FDA has approved Archimedes' application for Lazanda, a fentanyl spray for cancer patients with breakthrough pain. The system is already approved in five other countries under the name PecFent.

SCOUT data to fuel FDA diet-pill/cardio model

The FDA has tapped Archimedes to build a computer model of clinical trials evaluating weight-loss medications. The agency will use the model to contrast the benefits of weight loss against

UK driving school fronts execution drug wholesaler

The storefront-housed Elgone Driving Academy in West London is the site of the drug wholesaler that provided sodium thiopental to Arizona prison officials for use in inmate executions. It turns out

Imported death penalty drug to be tested by FDA

The anesthetic sodium thiopental purchased by California prison officials from a U.K. manufacturer will be tested by the FDA prior to use. It was shipped to the U.S. before the U.K. decided last

UK opts out as supplier of death penalty drug

The UK government plans to limit the export of a drug in short supply that is used in U.S. death penalty executions. Authorities would require manufacturers of the anesthetic sodium thiopental to

Report: Archimedes anesthetic used in Arizona execution

The Supreme Court has lifted a stay, leading to the execution of an Arizona inmate who questioned the state's source of sodium thiopental to be used in his lethal injection. The state had refused to

Archimedes snags EMA approval for new pain therapy

Archimedes Pharma says that European regulators have approved PecFent for breakthrough cancer pain as it pushes ahead with plans to mount a U.S. marketing effort--provided it wins a nod from the FDA.

Archimedes starts recruiting for new U.S. headquarters

Flush with investment cash and pushing apps for a new nasal spray treatment for breakthrough cancer pain in the U.S. and Europe, the UK's Archimedes Pharma says the time is ripe to establish a

Archimedes readies U.S. commercial ops for cancer pain

Yesterday's announcement that Archimedes Pharma had snared a $100 million bankroll from two big investors--Warburg Pincus and Novo A/S--leaves the company with a sizeable sum to roll out its new

Archimedes gets $100M bankroll and names a new CEO

The UK's Archimedes Pharma has raised $100 million from the equity arm of Novo A/S and Warburg Pincus--claiming the biggest European round for a biopharma company in 15 years--and hired former Enzon